Evidence map›Paper›PMID 42046745›Full record

ArticleCurrent medical mycology2025

Trend of

Conny Riana Tjampakasari, Yeva Rosana, Mardiastuti Wahid

Abstract read
In one paragraph

Article in Current medical mycology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Conny Riana TjampakasariDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia, Indonesia.
Yeva RosanaDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia, Indonesia.
Mardiastuti WahidDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Fungal infections are prevalent in tropical countries, and their etiology depends on various factors, including the underlying cause and accompanying risk factors. Accurate diagnosis through culture and identification is crucial to determine the causative agent, followed by antifungal susceptibility testing to guide appropriate management. Materials and Methods: This study was conducted during 2020-2024, consisting of 2,470 samples of various specimens. Samples were inoculated onto Sabouraud Dextrose Agar for fungal culture, and isolates were subsequently identified and subjected to antifungal susceptibility testing using the Vitek 2 compact automated system. Results: A total of 799 Conclusion: The trends in

Indexed as

Antifungal agentsAntifungal resistanceAntifungal susceptibilityCandida species

Identifiers

PMID42046745
PMCPMC13110379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.